Business Context and Reporting Period
This Form 8-K Current Report was filed by Nephros, Inc. on September 15, 2006. The report discloses a corporate governance event regarding the appointment of a new director to the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or performance data.
Material Changes
On September 15, 2006, the Board of Directors appointed Judy S. Slotkin as a director to fill a newly created vacancy. Ms. Slotkin has been appointed to serve on the Board's Audit Committee. The filing confirms there was no arrangement or understanding pursuant to which she was elected, and no material transactions involving her interest occurred in the last two years.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on financial performance, or discussion of risks and contingencies. It is a standard disclosure of a director appointment.
Key Facts for Investors
- New Director Appointment: Judy S. Slotkin was appointed to the Board of Directors and the Audit Committee.
- Background: Ms. Slotkin brings significant financial experience, including 16 years at Citigroup (most recently as Managing Director) and prior service as Co-Head of the Finance Committee for the Modern Africa Fund.
- Independence: The company states there were no special arrangements for her election and no material conflicts of interest in recent transactions.
- Financial Data: No financial metrics are disclosed in this specific filing.